Compound ID | 6
AVP-21D9 (Thravixa)
Class: Antibody
| Spectrum of activity: | Gram-positive |
| Details of activity: | Bacillus anthracis |
| Institute where first reported: | Emergent BioSolutions, USA |
| Year first mentioned: | 2011 |
| Highest developmental phase: | Phase 1 (NCT01202695) |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/160671699 |
| Guide to Pharmacology: | AVP-21D9 |
| Citation: | http://aac.asm.org/content/58/7/3618.full |
| Patent: | US20060246079A1 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.